Genetic medicines for CF: Hype versus reality. (2016)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ppul.23543
PubMed Identifier: 27662105
Publication URI: http://europepmc.org/abstract/MED/27662105
Type: Journal Article/Review
Volume: 51
Parent Publication: Pediatric pulmonology
Issue: S44
ISSN: 1099-0496